Gonorrhea Guideline Update in UK Guards Against Antibiotic Resistance - Contagionlive.com

-
A new guideline on the management of gonorrhea has been issued by the British Association for Sexual Health and HIV. The 2019 guideline introduced changes made to the 2011 guideline including: removing the recommendation for dual therapy with azithromycin, increasing the dose of ceftriaxone, recommending the use of ciprofloxacin in certain cases, and adding extra-genital testing in cases of known or suspected antimicrobial resistance.

“These new guidelines set out the latest evidence-based recommendations for the management and treatment of gonorrhea,” said Olwen Williams, FRCP, FLSW, President of the British Association for Sexual Health and HIV (BASHH).

Olwen added that updating the guidelines has been a “major priority for BASHH in recent months” due to the concerning spread of antibiotic-resistant strains of gonorrhea (GC).

There has been a growing awareness across Europe of antibiotic-resistant strains of gonorrhea. In September 2018, the European Center for Disease Prevention and Control released data showing that strains of Neisseria gonorrhea resistant to azithromycin were found in samples from a growing number of countries in the European Union/European Economic Area. Additionally, the first UK cases of ceftriaxone- and azithromycin-resistant gonorrhea were reported in early 2019 by Public Health England.

Given the rise of resistance to azithromycin, the 2019 guideline no longer recommends its use in dual therapy for gonorrhea. Instead, the recommended first line treatment is now monotherapy with ceftriaxone 1 g, an increase from the previously recommended dose of 500 mg. The guideline notes that though the lower dose of ceftriaxone would be sufficient to treat a majority of strains found the UK, data show that the 1 g dose would be “more effective” against strains with lower susceptibility.

With the aim of delaying resistance to ceftriaxone, the guideline recommends the use of ciprofloxacin when testing shows susceptibility at all sites of infection. Additionally, the guideline notes that ciprofloxacin should not be used in patients who have experienced previous serious side effects from a fluoroquinolone or quinolone antibiotic.

The guideline also recommends extra-genital testing for patients with known or suspected antimicrobial resistance.

Suneeta Soni, FRCP, Consultant in sexual health and HIV and co-author of BASHH GC guidelines, told MD Magazine® that the guideline strongly emphasizes culturing all patients with suspected or confirmed gonorrhea, “not only for surveillance purposes but also so that highly drug-resistant strains can be identified early.”

“The guidelines also recommend test of cure in ALL individuals with gonorrhea which significantly adds to current clinic workloads,” added Soni.

Due to a recent spending review in the UK which led to budget cuts, Soni said implementing the culturing and test of cure recommendations will present a challenge to clinicians.

“We hope that this new guidance will further strengthen antimicrobial stewardship initiatives and reduce the risk of onward transmission of the infection. We urge all health care professionals involved in the management of gonorrhea to implement these new guidelines as quickly and thoroughly as possible,” added Williams.

The guideline, “British Association for Sexual Health and HIV national guideline for the management of infection with Neisseria gonorrhoeae (2019),” was published in January 2019.

The article, "UK Gonorrhea Guideline Guards Against Antibiotic Resistance," was originally publishd on MDMag.com.

To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.


http://bit.ly/2Sdu26p

Comments

Post a Comment

Popular posts from this blog

Manual on meat inspection for developing countries

-
Image
sinusitis treatment :: Article Creator My 'sinus Infection' Turned Out To Be A One In A Million Nasal Cancer At Just 28 - And Doctors Had To Cut My Eye Out To Save Me By Emily Joshu Health Reporter For Dailymail.Com Published: 06:33 EDT, 20 April 2024Updated: 06:35 EDT, 20 April 2024 A 28 year-old California woman has described the shock of being diagnosed with a deadly sinus cancer that affects fewer than one in a million people - and led to the removal of her right eye. The 'golf ball-sized tumor', which had spread throughout her face, was first mistaken for a sinus infection by the woman's doctors.  Annika, who posts about her condition on TikTok, woke up one morning in 2023 and noticed that the inner corner of her right eye was sore.  While she at first thought nothing of it, by the time the evening rolled around, 'my face started to really, really hurt on the right side,' she said in a video.  The next day, her
Read more

Rash behind ear: Causes, other symptoms, and treatment - Medical News Today

-
Image
A rash behind the ear may occur due to a variety of different medical conditions. Certain viral infections and autoimmune diseases may cause a rash behind the ear in both children and adults. While some causes, such as contact dermatitis, are not concerning, other causes, including rubella, may be more serious. In this article, we look at some of the causes of a rash behind the ear, as well as the other symptoms that they may produce and how to treat them. Contact dermatitis is an allergic reaction to a particular substance. If an allergy-inducing substance comes into contact with the skin behind the ear, a rash can form. Allergens that may cause contact dermatitis behind the ears include: shampoos soaps other hair care products For example, hair dye products contain an ingredient called paraphenylenediamine (PPD), which is a common contact allergen. Symptoms Contact dermatitis causes itchiness, dryness, and flaking of the skin that came into contact with the allergen. Diagnosis A doc
Read more

Having This One Particular Blood Type Can Help Protect You From Severe Malaria - ScienceAlert

-
Image
Nearly  half the world's population is at risk of malaria, one of the most deadly diseases known to humankind. Each year it claims  over 400,000 lives, most of whom are children younger than age five. While it's possible to vaccinate against malaria, virtually all of these cases are in the African region, where protection is often nothing more than a roll of the dice. Now, a recent  analysis  of 23 papers suggests those with blood type O have the genetic odds stacked in their favour. In sub-Saharan Africa, where severe malaria - caused by the  Plasmodium falciparum  parasite  - is endemic, there are far more individuals with blood type O than anywhere in Europe or the US. In Nigeria alone, where 97 percent of the country is at risk of malaria, more than half the population belongs to this blood group. In Ethiopia and many others, the numbers are similar. Rather than a coincidence, co-author and epidemiologist Abraham Degarege Mengist from Robert Stempel College of Publi
Read more